| Literature DB >> 34909349 |
Abdulrahman M Alhassan1, Mohammed N Alghunaim2, Ayyob A Alqarni2, Abdulkareem M Abdullah1, Mohammed K Altoyan1, Abdullah S Alharbi3, Faisal A Alhusain4.
Abstract
Background Incisional hernia post organ transplant increases morbidity and impacts quality of life among patients undergoing abdominal organ transplants. Objectives To estimate the incidence rate of incisional hernia and the factors associated with incisional hernia among patients who underwent liver and kidney transplants. Methods This was a retrospective cohort study in which all patients from 2015 to 2020 who underwent liver and/or kidney transplants and met inclusion criteria were involved. Results A total of 424 patients who received transplantation surgery were included. Out of them, 287 patients (67.6%) underwent kidney transplants while 132 patients (31.1%) underwent a liver transplant. Additionally, five patients (1.1%) received both liver and kidney transplantation. Fourteen patients (3.3%) experienced incisional hernia across all samples. A higher incidence rate was noticed among patients with liver transplants compared to kidney transplants (6.81% in the liver group vs 1.7% in the kidney group), which showed a statistical significance between the two groups (P-value= 0.007). In multivariate analysis, surgical site infection (SSI), donor type, acute organ rejection, mycophenolate mofetil (MMF), and diabetes were all not predictors of incisional hernia among the patients. Conclusion Incisional hernia incidence in between the groups was within the global range of incisional hernia incidence among abdominal organ transplant patients, with a higher incidence among liver transplant patients. All factors associated with incisional hernia, such as SSI, DM, and old age, didn't show significance as predictors to incisional hernia formation among the samples.Entities:
Keywords: factors of incisional hernia; incisional hernia; kidney transplant; liver transplant; post transplant incisional hernia
Year: 2021 PMID: 34909349 PMCID: PMC8653929 DOI: 10.7759/cureus.20223
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Description of demographic data of liver and kidney transplants
ATG: Anti-thymocyte globulin; MELD: Model end-organ liver disease; SSI: Surgical site infection
| Variables | Type of transplant | ||
| Kidney | Liver | p-value | |
| Number (%) Mean±SD | Number (%) Mean±SD | ||
| Number of patients | 287 | 132 | |
| Gender | |||
| Male | 168 (58.5%) | 85 (64.4%) | 0.25 |
| Female | 119 (41.5%) | 47 (35.6%) | |
| Age | 45.57±15.30 | 58.79±10.35 | |
| <60 years | 212 (73.9%) | 55 (41.7%) | 0.001 |
| ≥60 years | 75 (26.1%) | 77 (58.3%) | |
| BMI | |||
| <30 | 152 (54.9%) | 72 (56.7%) | 0.73 |
| ≥30 | 125 (45.1%) | 55 (43.3%) | |
| Diabetes | 91 (32.3%) | 76 (57.6%) | 0.001 |
| Tracolimus | 276 (96.2%) | 124 (93.9%) | 0.30 |
| Mycophenolate | 270 (94.1%) | 105 (79.5%) | 0.001 |
| Basiliximab | 72 (25.1%) | 9 (6.8%) | 0.001 |
| ATG | 89 (31.0%) | 1 (0.8%) | 0.001 |
| History of abdominal surgery | 65 (22.6%) | 23 (17.4%) | 0.22 |
| Delayed graft function kKidney only) | 21 (7.4%) | ___ | |
| MELD score (liver only) | 19.02±6.96 | ___ | |
| Donor | |||
| Living | 223 (77.7%) | 50 (37.9%) | 0.001 |
| Deceased | 64 (22.3%) | 82 (62.1%) | |
| Acute organ rejection | 31 (11.0%) | 11 (8.3%) | 0.41 |
| SSI | 6 (2.1%) | 3 (2.3%) | 0.90 |
| Incisional hernia | 5 (1.7%) | 9 (6.8%) | 0.007 |
Basic characteristic of patients with both liver and kidney transplants
ATG: Anti-thymocyte globulin; DGF: Delayed graft function; SSI: Surgical site infection
| Patients have Both Liver and Kidney transplants | Variables | Number of patients. Mean±SD |
| Number of patients | 5 | |
| Gender (Female) | 4 | |
| Age (≥ 60 years) | 2 | |
| BMI (≥30) | 2 | |
| Diabetes | 2 | |
| Tracolimus | 5 | |
| Mycophenolate | 5 | |
| Basiliximab | 1 | |
| ATG | 1 | |
| History of abdominal surgery | 0 | |
| DGF | 1 | |
| Donor (deceased) | 5 | |
| Acute organ rejection | 1 | |
| SSI | 0 | |
| Incisional hernia | 0 |
Figure 1Different variables with the corresponding p-value in relation to the type of transplant
ATG: Anti-thymocyte globulin; SSI: Surgical site infection
Univariate logistic regression of the variables studied as predictors to incisional hernia
ATG: Anti-thymocyte globulin; SSI: Surgical site infection
| Variables | OR | 95% CI | P-value | |
| Lower | Upper | |||
| Gender (male) | 1.66 | 0.51 | 5.40 | 0.39 |
| Type of transplant (kidney transplant) | 0.24 | 0.08 | 0.73 | 0.013 |
| Age (< 60 years) | 0.14 | 0.04 | 0.53 | 0.003 |
| BMI (< 30) | 1.46 | 0.48 | 4.45 | 0.50 |
| Diabetes | 2.75 | 0.90 | 8.37 | 0.07 |
| Tracolimus | 3.80 | 0.78 | 18.35 | 0.09 |
| Mycophenolate | 0.64 | 0.08 | 5.07 | 0.67 |
| Basiliximab | 1.45 | 0.31 | 6.62 | 0.62 |
| ATG | 1.66 | 0.36 | 7.58 | 0.50 |
| History of abdominal surgery | 0.65 | 0.20 | 2.13 | 0.48 |
| Donor (living) | 0.38 | 0.13 | 1.13 | 0.08 |
| Acute organ rejection | 1.50 | 0.32 | 6.96 | 0.60 |
| SSI | 3.81 | 0.44 | 32.80 | 0.22 |
Multivariate logistic regression model for patients' characteristics, medications, and transplant related outcomes as predictors to incisional hernia
ATG: Anti-thymocyte globulin; SSI: Surgical site infection
| Variables | OR | 95% CI | P-value | |
| Lower | Upper | |||
| Gender (male) | 1.66 | 0.51 | 5.40 | 0.88 |
| Type of transplant (kidney transplant) | 0.24 | 0.08 | 0.73 | 0.43 |
| Age (< 60 years) | 0.14 | 0.04 | 0.53 | 0.052 |
| BMI (< 30) | 1.46 | 0.48 | 4.45 | 0.24 |
| Diabetes | 2.75 | 0.90 | 8.37 | 0.50 |
| Tracolimus | 3.80 | 0.78 | 18.35 | 0.06 |
| Mycophenolate | 0.64 | 0.08 | 5.07 | 0.23 |
| Basiliximab | 1.45 | 0.31 | 6.62 | 0.57 |
| ATG | 1.66 | 0.36 | 7.58 | 0.96 |
| History of abdominal surgery | 0.65 | 0.20 | 2.13 | 0.66 |
| Donor (living) | 0.38 | 0.13 | 1.13 | 0.33 |
| Acute organ rejection | 1.50 | 0.32 | 6.96 | 0.77 |
| SSI | 3.81 | 0.44 | 32.80 | 0.74 |